United StatesClindamycin Phosphate USP 1% (10 mg/mL) topical solution, 60 mL applicator bottles (Rx only), NDC 51672-4081-4 — lots AD30154, AD31143, AD31145, exp 11/30/2025, manufactured by Taro Pharmaceutical Industries Ltd. and distributed by Taro Pharmaceuticals USA — is being recalled by Sun Pharmaceutical Industries Inc. The recall was initiated because testing found out-of-specification results for total impurities and for assay (failed impurities/degradation).
What's being recalled
Clindamycin Phosphate USP, 1% (10 mg/mL), Topical Solution, 60 mL per applicator bottle, Rx only, Mfd. by: Taro Pharmaceutical Industries Ltd., Haifa Bay, Israel; Dist. by: Taro Pharmaceuticals USA, Inc., Hawthorne, NY 10532, NDC# 51672-4081-4
Recalling firm: Sun Pharmaceutical Industries Inc, Princeton, NJ, United States.
How to identify it
Lot#: AD30154, AD31143, AD31145, Exp 11/30/2025
The hazard
Failed Impurities/Degradation: Out of Specification results for Total Impurities and for Assay.
What to do
Don't stop taking a prescribed medicine without talking to your doctor or pharmacist first. For other products, stop using them and ask the pharmacist, seller or maker what to do.
The notice doesn't give instructions for consumers, so this is general advice for health & beauty recalls. Check the official notice for the details.
Where it was sold
Nationwide in the USA.
The official notice
This page is a summary of the notice published by U.S. Food and Drug Administration (enforcement reports), collected from U.S. Food and Drug Administration (enforcement reports). Check the original before you act on it.
Read the official notice (opens in a new tab)